US20160058736A1 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes - Google Patents

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Download PDF

Info

Publication number
US20160058736A1
US20160058736A1 US14/844,297 US201514844297A US2016058736A1 US 20160058736 A1 US20160058736 A1 US 20160058736A1 US 201514844297 A US201514844297 A US 201514844297A US 2016058736 A1 US2016058736 A1 US 2016058736A1
Authority
US
United States
Prior art keywords
diabetes
present
compounds
compound
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/844,297
Other versions
US9517228B2 (en
Inventor
John F McElroy
Robert J Chorvat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jenrin Discovery LLC
Original Assignee
Jenrin Discovery LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261675806P priority Critical
Priority to US201361787214P priority
Priority to US13/950,195 priority patent/US8680131B2/en
Priority to US14/191,922 priority patent/US9133127B2/en
Priority to US14/844,297 priority patent/US9517228B2/en
Application filed by Jenrin Discovery LLC filed Critical Jenrin Discovery LLC
Assigned to JENRIN DISCOVERY, INC. reassignment JENRIN DISCOVERY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHORVAT, ROBERT J, MCELROY, JOHN F
Publication of US20160058736A1 publication Critical patent/US20160058736A1/en
Application granted granted Critical
Publication of US9517228B2 publication Critical patent/US9517228B2/en
Assigned to JENRIN DISCOVERY, LLC reassignment JENRIN DISCOVERY, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: JENRIN DISCOVERY, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links